Bio-Rad Laboratories Inc
Suletud
SektorTervishoid
278.8 2.85
Ülevaade
Aktsiahinna muutus
24h
Min
269.92
Max
283.35
Sissetulek | -731M -11M |
|---|---|
Müük | -101M 592M |
P/E Sektori keskmine | 46.696 50.958 |
Aktsiakasum | 1.89 |
Kasumimarginaal | -1.858 |
Töötajad | 7,450 |
EBITDA | -751M -637M |
Soovitused | Neutraalne |
|---|---|
12 kuu keskmine prognoos | +11.44% upside |
Järgmine tulemuste avaldamine | 30. juuli 2026 |
|---|
Turukapital | -235M 7.5B |
|---|---|
Eelmine avamishind | 275.95 |
Eelmine sulgemishind | 278.8 |
Uudiste sentiment
By Acuity
50%
50%
143 / 342 Pingereas Healthcare
Bio-Rad Laboratories Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.